Trial Profile
Retrospective trial of sorafenib in High-Risk post-transplant patients with hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Feb 2016 New trial record